Activity of combinations of uracil mustard (NSC-34462) and 3-ethoxy-2-oxobutyraldehyde bis(thiosemicarbazone) [KTS; NSC-82116] against murine tumors.
D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002279:Carcinoma 256, Walker / Q000188:drug therapy*; D004357:Drug Synergism; D005260:Female; D008297:Male; D051379:Mice; D009374:Neoplasms, Experimental / Q000188:drug therapy*; D051381:Rats; D014499:Uracil Mustard / Q000627:therapeutic use*
D000970:Antineoplastic Agents; D014499:Uracil Mustard